Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Conroy

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Agents and Actions|June 1, 1989
In vitro effects of the antiallergy compound, CI-949, on interleukin-1 and 2 release, and on mitogen and alloantigen responsivenessR B Gilbertsen, K M Cullinen, D J Wilburn, et al.
Differentiation; Research in Biological Diversity|January 1, 1983
Spontaneous, in vitro, malignant transformation of a basophil/mast cell lineP E Ball, M C Conroy, C H Heusser, et al.
Biochemical and Biophysical Research Communications|March 16, 1990
Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-949: mechanism of inhibitory activityC D Wright, P J Kuipers, M D Hoffman, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1995
[Comparative study of four commercialized serologic methods for the diagnosis of gastric Helicobacter pylori infection]C Antoine, A Lozniewski, J D De Korwin, et al.
Diagnostic Immunology|January 1, 1986
Histamine release from human leukocytes by anti-IgE antibodies: influence of multiple or single epitope recognitionM A Kings, M C Conroy, B M Stadler, et al.
Journal of Medicinal Chemistry|July 1, 1991
Novel thiophene-, pyrrole-, furan-, and benzenecarboxamidotetrazoles as potential antiallergy agentsM D Mullican, R J Sorenson, D T Connor, et al.
The Journal of Allergy and Clinical Immunology|December 1, 1990
Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949M C Conroy, J A Kennedy, J C Chestnut, et al.
The Journal of Biological Chemistry|April 29, 1994
Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysinV M Baragi, C J Fliszar, M C Conroy, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft modelA Lozniewski, A Duprez, C Renault, et al.
Biochemical and Biophysical Research Communications|August 15, 1991
Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972R B Gilbertsen, M K Dong, L M Kossarek, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Agents and Actions|June 1, 1989
In vitro effects of the antiallergy compound, CI-949, on interleukin-1 and 2 release, and on mitogen and alloantigen responsivenessR B Gilbertsen, K M Cullinen, D J Wilburn, et al.
Differentiation; Research in Biological Diversity|January 1, 1983
Spontaneous, in vitro, malignant transformation of a basophil/mast cell lineP E Ball, M C Conroy, C H Heusser, et al.
Biochemical and Biophysical Research Communications|March 16, 1990
Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-949: mechanism of inhibitory activityC D Wright, P J Kuipers, M D Hoffman, et al.
Gastroenterologie Clinique Et Biologique|February 1, 1995
[Comparative study of four commercialized serologic methods for the diagnosis of gastric Helicobacter pylori infection]C Antoine, A Lozniewski, J D De Korwin, et al.
Diagnostic Immunology|January 1, 1986
Histamine release from human leukocytes by anti-IgE antibodies: influence of multiple or single epitope recognitionM A Kings, M C Conroy, B M Stadler, et al.
Journal of Medicinal Chemistry|July 1, 1991
Novel thiophene-, pyrrole-, furan-, and benzenecarboxamidotetrazoles as potential antiallergy agentsM D Mullican, R J Sorenson, D T Connor, et al.
The Journal of Allergy and Clinical Immunology|December 1, 1990
Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949M C Conroy, J A Kennedy, J C Chestnut, et al.
The Journal of Biological Chemistry|April 29, 1994
Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysinV M Baragi, C J Fliszar, M C Conroy, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
Gastric penetration of amoxicillin in a human Helicobacter pylori-infected xenograft modelA Lozniewski, A Duprez, C Renault, et al.
Biochemical and Biophysical Research Communications|August 15, 1991
Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972R B Gilbertsen, M K Dong, L M Kossarek, et al.
Pageof 6